tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

INSM Stock Latest News

Insmed price target lowered to $109 from $110 at UBS
The FlyInsmed price target lowered to $109 from $110 at UBS
11h ago
INSM
Insmed Reports Strong Q1 2025 Growth and Progress
PremiumCompany Announcements
Insmed Reports Strong Q1 2025 Growth and Progress
20h ago
INSM
Insmed’s Promising Pipeline and Strong Financials Justify Buy Rating
PremiumRatings
Insmed’s Promising Pipeline and Strong Financials Justify Buy Rating
22h ago
INSM
Insmed’s Strategic Growth and Pipeline Progress Drive Buy Rating
PremiumRatings
Insmed’s Strategic Growth and Pipeline Progress Drive Buy Rating
22h ago
INSM
Insmed’s Promising Future: Buy Rating Backed by Brensocatib Launch and Strong Clinical Pipeline
PremiumRatings
Insmed’s Promising Future: Buy Rating Backed by Brensocatib Launch and Strong Clinical Pipeline
22h ago
INSM
Insmed’s Earnings Call: Strong Growth and Optimistic Outlook
PremiumCompany AnnouncementsInsmed’s Earnings Call: Strong Growth and Optimistic Outlook
1d ago
INSM
Insmed reports Q1 EPS ($1.42), consensus ($1.36)
Premium
The Fly
Insmed reports Q1 EPS ($1.42), consensus ($1.36)
2d ago
INSM
Insmed backs FY25 global ARIKAYCE revenue view $405M-$425M
Premium
The Fly
Insmed backs FY25 global ARIKAYCE revenue view $405M-$425M
2d ago
INSM
INSM Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
INSM Upcoming Earnings Report: What to Expect?
4d ago
INSM
Insmed says NEJM publishes ‘positive’ results from Phase 3 ASPEN study
PremiumThe Fly
Insmed says NEJM publishes ‘positive’ results from Phase 3 ASPEN study
16d ago
INSM
Insmed’s Brensocatib: A Promising Solution for Bronchiectasis in AATD Patients
PremiumRatings
Insmed’s Brensocatib: A Promising Solution for Bronchiectasis in AATD Patients
18d ago
INSM
Insmed’s Strategic Positioning and Growth Potential Justify Buy Rating Despite Leadership Change
PremiumRatings
Insmed’s Strategic Positioning and Growth Potential Justify Buy Rating Despite Leadership Change
19d ago
INSM
Insmed’s Chief Commercial Officer Resigns for Personal Reasons
PremiumCompany AnnouncementsInsmed’s Chief Commercial Officer Resigns for Personal Reasons
22d ago
8K
INSM
Insmed’s Growth Potential: Buy Rating Backed by TPIP’s Market Promise and Strong Sales Projections
Premium
Ratings
Insmed’s Growth Potential: Buy Rating Backed by TPIP’s Market Promise and Strong Sales Projections
26d ago
INSM
Insmed participates in a conference call with Cantor Fitzgerald
Premium
The Fly
Insmed participates in a conference call with Cantor Fitzgerald
1M ago
INSM
Insmed’s Promising Pipeline and Market Potential Drive Buy Rating
PremiumRatings
Insmed’s Promising Pipeline and Market Potential Drive Buy Rating
1M ago
INSM
Insmed price target raised to $96 from $92 at BofA
PremiumThe Fly
Insmed price target raised to $96 from $92 at BofA
2M ago
INSM
United Therapeutics price target lowered to $314 from $328 at BofA
PremiumThe Fly
United Therapeutics price target lowered to $314 from $328 at BofA
2M ago
INSM
LQDA
Innovative Gene Therapy Approach Drives Buy Rating for Insmed in DMD Treatment
PremiumRatings
Innovative Gene Therapy Approach Drives Buy Rating for Insmed in DMD Treatment
2M ago
INSM
Insmed assumed with an Overweight at Morgan Stanley
PremiumThe FlyInsmed assumed with an Overweight at Morgan Stanley
2M ago
INSM
Insmed’s Strategic Growth and Promising Pipeline Drive Buy Rating
Premium
Ratings
Insmed’s Strategic Growth and Promising Pipeline Drive Buy Rating
2M ago
INSM
Insmed price target raised to $110 from $105 at UBS
Premium
The Fly
Insmed price target raised to $110 from $105 at UBS
2M ago
INSM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >